Tema Cardiovascular and Metabolic ETF – NASDAQ:HRTS

Add to watchlist

$29.15

-0.30

-1.02%

Market closed

Open in about 17 hours

-16.78%

month

-16.78%

quarter

-4.83%

year

Market Cap	80.68M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Tema Cardiovascular and Metabolic ETF
Latest News

Thursday, 21 November 2024
15:35	Disruptive Theme of the Week – Breakthroughs in Medicine	etftrends.com
Wednesday, 16 October 2024
14:51	Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win	zacks.com
Wednesday, 18 September 2024
12:00	Tap the Weight-Loss Drug Market With These ETFs	zacks.com
Wednesday, 14 August 2024
08:39	Disruptive Theme of the Week: Playing Defense	etftrends.com
Saturday, 27 July 2024
10:23	How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)	invezz.com
Thursday, 25 July 2024
07:00	HRTS: Generating Alpha In Obesity Treatment	seekingalpha.com
Monday, 22 July 2024
15:11	ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment	zacks.com
Friday, 19 July 2024
10:59	HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside	seekingalpha.com
Monday, 17 June 2024
14:46	Looking at Next Gen of Weight Loss: Tema ETFs CEO	youtube.com
Wednesday, 22 May 2024
09:41	Play These New ETFs to Tap Lucrative Weight Loss Drug Market	zacks.com
Monday, 13 May 2024
15:32	Fighting Obesity Using ETFs	ETF Trends
Tuesday, 7 May 2024
17:46	Thematic ETF Winners of the Q1 2024 Earnings Season	ETF Trends

Frequently Asked Questions (FAQ)

What's the price of Tema Cardiovascular and Metabolic ETF stock today?

One share of Tema Cardiovascular and Metabolic ETF stock can currently be purchased for approximately $29.15.
When is Tema Cardiovascular and Metabolic ETF's next earnings date?

Unfortunately, Tema Cardiovascular and Metabolic ETF's (HRTS) next earnings date is currently unknown.
Does Tema Cardiovascular and Metabolic ETF pay dividends?

No, Tema Cardiovascular and Metabolic ETF does not pay dividends.
How much money does Tema Cardiovascular and Metabolic ETF make?

Tema Cardiovascular and Metabolic ETF has a market capitalization of 80.68M.
What is Tema Cardiovascular and Metabolic ETF's stock symbol?

Tema Cardiovascular and Metabolic ETF is traded on the NASDAQ under the ticker symbol "HRTS".
What is Tema Cardiovascular and Metabolic ETF's primary industry?

Company operates in the Financial Services sector and Asset Management industry.
How do i buy shares of Tema Cardiovascular and Metabolic ETF?

Shares of Tema Cardiovascular and Metabolic ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

Tema Cardiovascular and Metabolic ETF

Exchange:

NASDAQ

Full time employees:

Industry:

Asset Management

Sector:

Financial Services

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.

CIK: 0001387131
ISIN: US87975E8839
: